5AM Opportunities I (GP), LLC, 10% Owner at Aprea Therapeutics, Inc. (APRE), sold 280,000 shares at $33.30 ($9.3M) on 2020-06-16, disclosed to the SEC on 2020-06-18.
Open-market sale of $9.3M APRE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.30 | 4,807 | $160K | 1.7% |
| 2 | $33.30 | 4,807 | $160K | 1.7% |
| 3 | $33.30 | 19,836 | $661K | 7.1% |
| 4 | $33.30 | 19,836 | $661K | 7.1% |
| 5 | $33.30 | 115,357 | $3.8M | 41.2% |
| 6 | $33.30 | 115,357 |
| $3.8M |
| 41.2% |
| Total | $33.30 avg | 280,000 | $9.3M | 100% |
| Filing → |
| SCPH | SELL | 2022-04-13 | $1.4M | — | Filing → |
| VOR | BUY | 2021-02-09 | $10.0M | — | Filing → |
| APRE | SELL | 2020-10-07 | $4.4M | — | Filing → |